Chugai Pharmaceutical Co Ltd (MEX:4519N)
MXN 825.61 (0%) Market Cap: 1.31 Tn Enterprise Value: 1.21 Tn PE Ratio: 26.66 PB Ratio: 6.32 GF Score: 97/100

Q1 2025 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript

Apr 24, 2025 / 09:00AM GMT
Release Date Price: MXN1121.87 (+22.29%)

Apr 24, 2025 / 09:00AM GMT
Presentation
Apr 24, 2025 / 09:00AM GMT

=====================
Corporate Participants
=====================
* Kae Miyata
Chugai Pharmaceutical Co Ltd - Head of Corporate Communications Department
* Osamu Okuda
Chugai Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Kusano Tsukasa
Chugai Pharmaceutical Co Ltd - Executive Vice President Supervisory responsibility for Project & Lifecycle Management
* Iwaaki Taniguchi
Chugai Pharmaceutical Co Ltd - Director, Executive Vice President, and Chief Financial Officer
* Takano Junichi
Chugai Pharmaceutical Co Ltd - Head of Marketing & Sales Division

=====================
Conference Call Participants
=====================
* Matsubara-san
Nomura Securitie - Analyst
* Seiji Wakao
JPMorgan Securities - Analyst
* Shinichiro Muraoka
Morgan Stanley MUFG Securities - Analyst
* Hidemaru Yamaguchi
Citigroup Inc - Analyst
* Tony Ren
Macquarie Capital -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot